Do Symptoms and Quality of Life Differ between Focal and Diffuse Coronary Artery Disease?

Changes in fractional flow reserve (FFR) values after percutaneous coronary intervention (PCI) are associated with improvement in angina symptoms. The pattern of baseline coronary artery disease influences the degree of variation in FFR after stent implantation.

La coronariografía precoz reduce la mortalidad en SCA sin supradesnivel del ST de alto riesgo

Focal coronary artery disease leads to high post-PCI FFR values, while the improvement is not as marked in diffuse coronary artery disease. Baseline pattern of coronary disease can anticipate the likelihood of successful improvement in angina symptoms. However, the definition of diffuse disease has not been standardized and is often based on visual assessment, limiting its accuracy and repeatability.

Using the pullback pressure gradient (PPG) of the FFR, the aim of this subanalysis of the randomized, prospective, single-center study TARGET-FFR (Trial of Angiography vs. pressure-Ratio-Guided Enhancement Techniques-Fractional Flow Reserve) was to investigate the differential effect on patient-reported outcomes of PCI on focal (PPG ≥0.66) and diffuse (PPG <0.66) disease.

The endpoints were questionnaires to assess the presence of angina and patient quality of life.

A total of 103 patients were analyzed: 51 had focal disease and 52 had diffuse disease. There were no differences in baseline characteristics between the two groups. The mean PPG was 0.66. Patients with focal disease were treated with fewer (p = 0.022) and shorter (p = 0.015) stents. In addition, this population had higher post-PCI FFR values (p < 0.001) and greater change was observed after intervention (p < 0.001).

Read also: Pulmonary Artery Denervation: Valid Alternative for Pulmonary Arterial Hypertension Grade 1?

After PCI, almost 40% of patients experienced residual angina, which was significantly lower in patients with focal disease compared with diffuse disease (27.5% vs. 51.9%, respectively; p = 0.020). In addition, patients with focal coronary artery disease reported less angina, less physical limitation, and better quality of life.

On the other hand, after PCI, patients with focal disease experienced increased mobility and self-care, and decreased pain and discomfort. There were no differences in the presence of anxiety and/or depression between both groups.

Conclusion

Residual angina after PCI was frequent and found in patients with diffuse coronary disease defined as pre-PCI PPG. After PCI, patients with focal disease experienced angina improvement and better quality of life. PPG was useful to identify patients who would benefit from percutaneous revascularization in terms of symptomatic improvement.

Dr. Andrés Rodríguez.
Member of the editorial board of SOLACI.org.

Original Title: Differential Improvement in Angina and Health-Related Quality of Life After Percutaneous Coronary Interventions in Focal and Diffuse Coronary Artery Disease.

Reference: Carlos Collet, MD, PHD et al J Am Coll Cardiol Intv 2022.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...